{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T18:46:30Z","timestamp":1764873990403,"version":"3.37.3"},"reference-count":14,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T00:00:00Z","timestamp":1670198400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,5,2]]},"DOI":"10.1093\/rheumatology\/keac677","type":"journal-article","created":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T20:06:19Z","timestamp":1670270779000},"page":"1730-1732","source":"Crossref","is-referenced-by-count":1,"title":["More to B: the growing evidence to inform targeting B cells in scleroderma"],"prefix":"10.1093","volume":"62","author":[{"given":"Silvia Laura","family":"Bosello","sequence":"first","affiliation":[{"name":"UOC di Reumatologia, Universit\u00e0 Cattolica del Sacro Cuore, Fondazione Policlinico Universitario A. Gemelli, IRCCS , Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1637-4755","authenticated-orcid":false,"given":"Edward M","family":"Vital","sequence":"additional","affiliation":[{"name":"Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds , Leeds, UK"},{"name":"NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust , Leeds, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8528-2283","authenticated-orcid":false,"given":"Francesco","family":"Del Galdo","sequence":"additional","affiliation":[{"name":"Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds , Leeds, UK"},{"name":"NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust , Leeds, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2022,12,5]]},"reference":[{"key":"2023050208175204800_keac677-B1","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/keac578","article-title":"The role of B cells in the pathogenesis of systemic sclerosis: an update","volume":"62","author":"Sakkas","year":"2023","journal-title":"Rheumatology"},{"key":"2023050208175204800_keac677-B2","doi-asserted-by":"crossref","first-page":"933468","DOI":"10.3389\/fimmu.2022.933468","article-title":"Role of B cell in the pathogenesis of systemic sclerosis","volume":"13","author":"Thoreau","year":"2022","journal-title":"Front Immunol"},{"key":"2023050208175204800_keac677-B3","doi-asserted-by":"crossref","first-page":"e834","DOI":"10.1016\/S2665-9913(21)00244-7","article-title":"Progression of patients with Raynaud's phenomenon to systemic sclerosis: a five-year analysis of the European Scleroderma Trial and Research group multicentre, longitudinal registry study for Very Early Diagnosis of Systemic Sclerosis (VEDOSS)","volume":"3","author":"Bellando-Randone","year":"2021","journal-title":"Lancet Rheumatol"},{"key":"2023050208175204800_keac677-B4","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1136\/annrheumdis-2021-220402","article-title":"Molecular basis for clinical diversity between autoantibody subsets in diffuse cutaneous systemic sclerosis","volume":"80","author":"Clark","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"2023050208175204800_keac677-B5","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1038\/s41591-022-02017-5","article-title":"Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus","volume":"28","author":"Mackensen","year":"2022","journal-title":"Nat Med"},{"key":"2023050208175204800_keac677-B6","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1007\/s10067-021-05698-4","article-title":"Efficacy and safety of rituximab therapy in patients with systemic sclerosis disease (SSc): systematic review and meta-analysis","volume":"40","author":"Moradzadeh","year":"2021","journal-title":"Clin Rheumatol"},{"key":"2023050208175204800_keac677-B7","doi-asserted-by":"crossref","first-page":"e489","DOI":"10.1016\/S2665-9913(21)00107-7","article-title":"Safety and efficacy of rituximab in systemic sclerosis (DESIRES): a double-blind, investigator-initiated, randomised, placebo-controlled trial","volume":"3","author":"Ebata","year":"2021","journal-title":"Lancet Rheumatol"},{"journal-title":"Lancet Respir Med","article-title":"Rituximab versus intravenous cyclophosphamide in patients with connective tissue disease-associated interstitial lung disease in the UK (RECITAL): a double-blind, double-dummy, randomised, controlled, phase 2b trial","author":"Maher","key":"2023050208175204800_keac677-B8"},{"key":"2023050208175204800_keac677-B9","doi-asserted-by":"crossref","first-page":"4364","DOI":"10.1093\/rheumatology\/keac023","article-title":"Predictors of rituximab effect on modified Rodnan skin score in systemic sclerosis: a machine-learning analysis of the DesiReS trial","volume":"61","author":"Ebata","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"2023050208175204800_keac677-B10","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1136\/annrheumdis-2017-211191","article-title":"Predicting and managing primary and secondary non-response to rituximab using B-cell biomarkers in systemic lupus erythematosus","volume":"76","author":"Md Yusof","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2023050208175204800_keac677-B11","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1136\/annrheumdis-2014-206496","article-title":"Repeat cycles of rituximab on clinical relapse in ANCA-associated vasculitis: identifying B cell biomarkers for relapse to guide retreatment decisions","volume":"74","author":"Md Yusof","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2023050208175204800_keac677-B12","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1186\/s13075-016-1190-z","article-title":"Serum IL-33, a new marker predicting response to rituximab in rheumatoid arthritis","volume":"18","author":"Sellam","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"2023050208175204800_keac677-B13","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/art.37707","article-title":"The TTTT B lymphocyte stimulator promoter haplotype is associated with good response to rituximab therapy in seropositive rheumatoid arthritis resistant to tumor necrosis factor blockers","volume":"65","author":"Fabris","year":"2013","journal-title":"Arthritis Rheum"},{"key":"2023050208175204800_keac677-B14","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S2213-2600(20)30330-1","article-title":"Efficacy and safety of nintedanib in patients with systemic sclerosis-associated interstitial lung disease treated with mycophenolate: a subgroup analysis of the SENSCIS trial","volume":"9","author":"Highland","year":"2021","journal-title":"Lancet Respir Med"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keac677\/48001374\/keac677.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/62\/5\/1730\/50120896\/keac677.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/62\/5\/1730\/50120896\/keac677.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T08:24:00Z","timestamp":1683015840000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/62\/5\/1730\/6873732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,5]]},"references-count":14,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,12,5]]},"published-print":{"date-parts":[[2023,5,2]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keac677","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"type":"print","value":"1462-0324"},{"type":"electronic","value":"1462-0332"}],"subject":[],"published-other":{"date-parts":[[2023,5,1]]},"published":{"date-parts":[[2022,12,5]]}}}